Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px

News > All

Total search results: 9808 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
BioNTech SE. (4/22/20). "Press Release: BioNTech and Pfizer Announce Regulatory Approval from German Authority Paul-Ehrlich-Institut to Commence First Clinical Trial of COVID-19 Vaccine Candidates". Mainz & New York, NY. 2020-04-22
Evotec SE. (4/22/20). "Press Release: Evotec Regains Global Rights to Beta Cell Replacement Therapy". Hamburg. 2020-04-22
Valneva S.E.. (4/22/20). "Press Release: Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19". Saint-Herblain & Emeryville, CA. 2020-04-22
FoRx Therapeutics AG. (4/22/20). "Press Release: FoRx Therapeutics AG Raises EUR 10 Million Seed Round". Basel. 2020-04-22
Merck KGaA. (4/21/20). "Press Release: Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity". Darmstadt. 2020-04-21
Lunaphore Technologies S.A.. (4/21/20). "Press Release: Lunaphore Receives Additional CHF 2M in Series C2 Financing, Bringing Total Series C Round to CHF 25M". Lausanne. 2020-04-21
MorphoSys AG. (4/21/20). "Press Release: MorphoSys Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer". Planegg. 2020-04-21
ADC Therapeutics S.A.. (4/21/20). "Press Release: ADC Therapeutics Appoints Jennifer Creel as Chief Financial Officer". Lausanne. 2020-04-21
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/21/20). "Press Release: SHS Appoints Sascha Alilovic as Managing Partner". 2020-04-21
Eppendorf AG. (4/20/20). "Press Release: Eppendorf AG Posts a Strong Fiscal Year 2019. Revenue Rises to €803.9 Million (Prior Year: €729.2 Million)". Hamburg. 2020-04-20
Centogene B.V.. (4/17/20). "Press Release: Centogene and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19". Rostock & Cologne. 2020-04-17
Eurofins Scientific. (4/16/20). "Press Release: Eurofins Genomics Launches »SARS-CoV-2 Full-length Genome Sequencing« Service to Support Researchers Globally in Their Fight against the COVID-19 Pandemic and Outbreak Source Tracing". Ebersberg. 2020-04-16
Sphingotec GmbH. (4/16/20). "Press Release: SphingoTec Expands Leadership Team and Appoints Achim Plum as Managing Director and Chief Commercial Officer". Hennigsdorf. 2020-04-16
Evotec SE. (4/16/20). "Press Release: Evotec Enters Nanomedicine through Strategic Partnership with Leon-Nanodrugs". Hamburg. 2020-04-16
Cevec Pharmaceuticals GmbH. (4/16/20). "Press Release: Cevec Signs License Agreement for the Development and Commercialization of Exosomes for Therapeutic Use". Cologne. 2020-04-16
Evotec SE. (4/15/20). "Press Release: Just – Evotec Biologics Develops AI-driven Humanoid Antibody Library (“HAL”)". Seattle, WA. 2020-04-15
Centogene B.V.. (4/15/20). "Press Release: Centogene Announces Opening of Laboratory in Hamburg, Germany". Cambridge, MA, Rostock & Berlin. 2020-04-15
MOMA Therapeutics. (4/15/20). "Press Release: MOMA Therapeutics – Drugging the Molecular Machines that Underlie Human Disease". 2020-04-15
Halix B.V.. (4/15/20). "Press Release: Halix Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine". Leiden. 2020-04-15
Seeqc, Inc.. (4/9/20). "Press Release: Seeqc Gains Over $11 Million in Funding to Introduce Fully Digital Quantum Computing". Elmsford, NY. 2020-04-09
BioNTech SE. (4/9/20). "Press Release: Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development". Mainz & New York, NY. 2020-04-09
Sophia Genetics S.A.. (4/8/20). "Press Release: Sophia Genetics Expands its Executive Team, Naming Lara Hashimoto Chief Business Officer". Lausanne & Boston, MA. 2020-04-08
Arrakis Therapeutics, Inc.. (4/8/20). "Press Release: Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche for Multi-Target Program Utilizing RNA-Targeted Small Molecule Drug Discovery Platform". Waltham, MA. 2020-04-08
Neuro Event Labs Oy. (4/8/20). "Press Release: Neuro Event Labs Closes €3.9M Series A Round to Become the Standard for Epilepsy Diagnostics". 2020-04-08
Sirion Biotech GmbH. (4/7/20). "Press Release: Beam Therapeutics Licenses Sirion Biotech’s LentiBOOST Technology for Its CAR-T pipeline". Martinsried. 2020-04-07
Merck KGaA. (4/7/20). "Press Release: Merck Awarded Second U.S. Patent for CRISPR Gene-Editing Technology". Darmstadt. 2020-04-07
Roche. (4/7/20). "Press Release: Roche Provides Regulatory Update on Risdiplam for the Treatment of Spinal Muscular Atrophy (SMA)". Basel. 2020-04-07
Apeptico Forschung und Entwicklung GmbH. (4/7/20). "Press Release: Solatide Has Been Approved by the Austrian Federal Office for Safety in Health Care for the Treatment of COVID-19 Patients with Severe Pulmonary Dysfunction". Vienna. 2020-04-07
Evotec SE. (4/6/20). "Press Release: Evotec and Takeda Enter into Multi-year Gene Therapy Research Alliance". Hamburg. 2020-04-06
Evotec SE. (4/6/20). "Press Release: Evotec Expands into Gene Therapy. Evotec Establishes Gene Therapy R&D Site with more than 20 Experienced Scientis in Austria". Hamburg. 2020-04-06
BIO Deutschland. (4/6/20). "Press Release: German Biotechnology Companies Are Playing a Key Role in Combating the Corona Pandemic". Berlin. 2020-04-06
MorphoSys AG. (4/6/20). "Press Release: MorphoSys Provides Update on Impact of COVID-19 on Business Operations and Precautionary Measures". Planegg. 2020-04-06
Apeiron Biologics AG. (4/2/20). "Press Release: Apeiron Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19". Vienna. 2020-04-02
ERS Genomics Ltd.. (4/2/20). "Press Release: ERS Genomics and Axxam Announce CRISPR/Cas9 License Agreement to Enhance Discovery Services". Dublin & Milan. 2020-04-02
Evotec SE. (4/2/20). "Press Release: Evotec Expands Its iPSC-based Cell Therapy Platform Evocells through Licensing Agreement with PanCella". Hamburg & Toronto. 2020-04-02
Neurimmune AG. (4/1/20). "Press Release: Neurimmune and Ethris Sign Collaboration Agreement to Rapidly Develop Inhaled mRNA-based Antibody Therapy for the Treatment of Covid-19". Zurich & Munich. 2020-04-01
iTeos Therapeutics Inc.. (4/1/20). "Press Release: iTeos Therapeutics Closes $125 Million Series B2 Financing". Cambridge, MA & Gosselies. 2020-04-01
BioNTech SE. (3/31/20). "Press Release: BioNTech Announces Full Year 2019 Financial Results and Corporate Update". Mainz. 2020-03-31
InflaRx N.V.. (3/31/20). "Press Release: InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology". Jena. 2020-03-31
Danaher Corporation. (3/31/20). "Press Release: Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences, Business Will Be Called Cytiva". Washington, DC. 2020-03-31
Evotec SE. (3/31/20). "Press Release: Evotec and Ildong to Collaborate with Development Projects on INDiGO Platform". Hamburg. 2020-03-31
Merck KGaA. (31/3/20). "Press Release: Merck Successfully Divests Allergopharma". Darmstadt. 2020-03-31
Qiagen N.V.. (3/31/20). "Press Release: Qiagen Receives U.S. FDA EUA for QIAstat-Dx Test Kit, First and Only Syndromic Solution Integrating Detection of SARS-CoV-2 Coronavirus". Germantown, MD & Hilden. 2020-03-31
Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 million ($450 million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA. 2020-03-31
Numab Therapeutics AG. (3/30/20). "Press Release: Numab Therapeutics Expands Immuno-Oncology Research Alliance with Ono Pharmaceutical Co., Ltd.". Wädenswil (Zurich). 2020-03-30
Boehringer Ingelheim. (3/30/20). "Press Release: Boehringer Ingelheim Opens Second Branch of Digital Lab BI X in Shanghai". Shanghai. 2020-03-30
Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. 2020-03-27
Evotec SE. (3/27/20). "Press Release: Evotec Statement on COVID-19 (last updated 27 March 2020)". Hamburg. 2020-03-27
BioKryo GmbH. (3/27/20). "Press Release: BioKryo Biobanking Network Supports Clinical Trials". Sulzbach. 2020-03-27
SutroVax, Inc.. (3/26/20). "Press Release: SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia". Foster City, CA. 2020-03-26
Medigene AG. (3/26/20). "Press Release: Medigene Provides Results for Fiscal Year 2019 and Outlook". Martinsried. 2020-03-26
Randox Laboratories Ltd.. (3/26/20). "Press Release: Point of Care Coronavirus Test from Randox and Bosch Will Launch in April 2020". 2020-03-26
Bone Therapeutics S.A.. (3/26/20). "Press Release: Bone Therapeutics Appoints Stefanos Theoharis as Chief Business Officer". Gosselies. 2020-03-26
Evotec SE. (3/26/20). "Press Release: Evotec SE Fiscal Year 2019 Results". Hamburg. 2020-03-26
Sophia Genetics S.A.. (3/26/20). "Press Release: Sophia Genetics and Paragon Genomics Join Forces Against the COVID-19 Coronavirus Pandemic". Lausanne & Boston, MA. 2020-03-26
Proteona Pte. Ltd.. (25/3/20). "Press Release: Proteona Leads International Consortium to Develop SARS-CoV-2 Neutralizing Antibody to Help Vulnerable Immunocompromised Individuals". Singapore. 2020-03-25
Debiopharm International SA. (3/25/20). "Press Release: Debiopharm Expands Its Radiopharmaceutical Footprint with an Exclusive In-licensing Agreement of 3B Pharmaceutical’s Targeted CAIX Radiotherapy". Lausanne. 2020-03-25
Evotec SE. (3/25/20). "Press Release: Evotec Partner Forge Enters into Collaboration with Roche to Develop Novel Antibiotic". San Diego, CA. 2020-03-25
Forge Therapeutics, Inc.. (3/25/20). "Press Release: Forge Enters into Collaboration with Roche to Develop Novel Antibiotic to Treat Lung Infections". San Diego, CA. 2020-03-25
ProBioGen AG. (3/24/20). "Press Release: Immunogenesis Contracts ProBioGen for Development and Large-Scale Manufacturing Services". Berlin & Houston, TX. 2020-03-24
Qiagen N.V.. (3/24/20). "Press Release: Qiagen Names Thierry Bernard as Chief Executive Officer". Venlo, Hilden & Germantown, MD. 2020-03-24
Roche. (3/24/20). "Press Release: Roche Response to COVID-19 Pandemic". Basel. 2020-03-24
Genedata AG. (3/23/20). "Press Release: CytomX Therapeutics Deploys Genedata Bioprocess". South San Francisco, CA & Tokyo. 2020-03-23
Proteona Pte. Ltd.. (23/3/20). "Press Release: One More Step towards True Precision Medicine. Proteona, Synovo, and NMI Announced Collaboration on a Single Cell Multi-omics Profiling Platform for Patient-derived Micro-tumors". Singapore. 2020-03-23
Roche. (3/23/20). "Press Release: Roche Announces Venclexta/Venclyxto Combination Improved Overall Survival in People with Previously Untreated Acute Myeloid Leukaemia". Basel. 2020-03-23
AC Immune S.A.. (3/23/20). "Press Release: AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer Tau Partnership". Lausanne. 2020-03-23
Bayer AG. (23/3/20). "Press Release: Bayer and Curadev Sign Research Collaboration and License Agreement to Develop Novel STING Antagonists across Indications". Berlin & New Delhi. 2020-03-23
ADC Therapeutics S.A.. (3/19/20). "Press Release: ADC Therapeutics to Appoint Ron Squarer as Chairman of Its Board of Directors and an Advisor to the Company". Lausanne. 2020-03-19
Eppendorf AG. (3/19/20). "Press Release: Eppendorf Acquires Centrifuge Business of Koki Holdings Co., Ltd.". Hamburg & Tokyo. 2020-03-19
Oxford Biomedica plc. (3/18/20). "Press Release: Building the Group for Future Growth. Business Update". Oxford. 2020-03-18
OncoOne GmbH. (3/18/20). "Press Release: OncoOne Launches with EUR 13 Million Series A to Develop Multiple Drug Modalities for Unexplored Target". Klosterneuburg. 2020-03-18
Oxford Biomedica plc. (3/18/20). "Press Release: Oxford BioMedica Signs License & Clinical Supply Agreement with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, for LentiVector Platform for CAR-T and TCR-T Therapeutics". Oxford. 2020-03-18
Immatics Biotechnologies GmbH. (3/17/20). "Press Release: Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies". Houston, TX & Tübingen. 2020-03-17
Affimed N.V.. (3/17/20). "Press Release: Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer". Heidelberg. 2020-03-17
BioNTech SE. (3/17/20). "Press Release: Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine". New York, NY & Mainz. 2020-03-17
Evonik Industries AG. (3/17/20). "Press Release: Evonik Achieves Major Biotech Breakthrough with a New Animal-free and Fermentation-based Collagen Platform". 2020-03-17
ImCheck Therapeutics S.A.S.. (3/17/20). "Press Release: ImCheck Therapeutics Expands Leadership Team with Appointment of Hans Henrik Chrois Christensen as Chief Financial Officer and Chief Operating Officer". Marseille. 2020-03-17
BioNTech SE. (3/16/20). "Press Release: BioNTech Reports Rapid Progress on COVID-19 Vaccine Program to Address Global Public Health Threat". Mainz. 2020-03-16
BioNTech SE. (3/16/20). "Press Release: BioNTech and Fosun Pharma Form COVID-19 Vaccine Strategic Alliance in China". Mainz & Shanghai. 2020-03-16
CureVac AG. (3/16/20). "Press Release: CureVac Announces Leadership Update". Tübingen & Boston, MA. 2020-03-16
CureVac AG. (3/15/20). "Press Release: CureVac Focuses on the Development of mRNA-based Coronavirus Vaccine to Protect People Worldwide. The Company Rejects Current Rumors of an Acquisition". Tübingen & Boston, MA. 2020-03-15
dievini Hopp BioTech holding GmbH & Co. KG. (3/15/20). "Press Release: dievini nimmt Stellung zu Presseveröffentlichungen über ihre Beteiligungsgesellschaft". Walldorf. 2020-03-15
Life Science Nord Management GmbH. (3/11/20). "Press Release: Innovation Project Started – Digital Precision Medicine Made in Northern Germany". 2020-03-11
CureVac AG. (3/11/20). "Press Release: Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG". Tübingen & Boston, MA. 2020-03-11
Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. 2020-03-10
Genedata AG. (3/10/20). "Press Release: Chugai Implements Genedata Profiler to Accelerate Data-driven Biomarker Discovery". Tokyo. 2020-03-10
Thermo Fisher Scientific Inc.. (3/10/20). "Press Release: Thermo Fisher Scientific Names Paul G. Parker to Head Strategy and Corporate Development". Waltham, MA. 2020-03-10
Numab Therapeutics AG. (3/9/20). "Press Release: Numab Therapeutics Closes Series B Financing at CHF 22M to Advance Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology". Wädenswil (Zurich). 2020-03-09
UCB S.A.. (3/9/20). "Press Release: UCB Announces Appointment of Sandrine Dufour as New Chief Financial Officer". Brussels. 2020-03-09
High-Tech Gründerfonds Management GmbH. (3/9/20). "Press Release: High-Tech Gründerfonds and Bayern Kapital Invest in Digital Cardiology Clinic iAtros". 2020-03-09
Ubirch GmbH. (3/6/20). "Press Release: Cologne-based Blockchain-anchored Data Security Start-up Ubirch Completes Third Round of Financing". 2020-03-06
Orionis Biosciences. (3/5/20). "Press Release: Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets". Boston, MA & Ghent. 2020-03-05
Voluntis S.A.. (3/4/20). "Press Release: Voluntis Announces Its New Strategic Roadmap. Strategic Prioritization of the Oncology Business". Cambridge, MA & Paris. 2020-03-04
Calyxha Biotechnologies GmbH. (3/4/20). "Press Release: Calyxha Endeavors to Develop Novel Approaches to Tissue Degenerative Diseases and Receives Support from Austrian VC and International Investors". Vienna. 2020-03-04
BlueRock Therapeutics. (3/3/20). "Press Release: BlueRock Therapeutics Appoints Seth Ettenberg, Ph.D. Chief Scientific Officer". Cambridge, MA. 2020-03-03
Qiagen N.V.. (3/3/20). "Press Release: Thermo Fisher Scientific to Acquire Qiagen N.V.". Waltham, MA & Venlo. 2020-03-03
Qiagen N.V.. (3/3/20). "Press Release: Conclusion of a Business Combination Agreement between Qiagen N.V. and Thermo Fisher Scientific Inc., Announcement of a Public Tender Offer by Thermo Fisher Scientific Inc. [Ad hoc]". Venlo. 2020-03-03
Merck KGaA. (3/2/20). "Press Release: Erbitux Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Not intended for UK-based media]". Darmstadt. 2020-03-02
Thermo Fisher Scientific Inc.. (3/2/20). "Press Release: New Advanced Liquid Chromatography System Delivers Productivity, Precision and Compliance in Routine Analyses". Germering. 2020-03-02
CureVac AG. (3/2/20). "Press Release: CureVac CEO Daniel Menichella Discusses Coronavirus Vaccine Development with U.S. President Donald Trump and Members of Coronavirus Task Force". Tübingen. 2020-03-02
next pagenext page 1 2 3 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group ChinaBio Partnering Forum 2020 Digital Event CBPF2020 650x80

» top